# ADCK1

## Overview
ADCK1, or aarF domain containing kinase 1, is a gene that encodes a protein belonging to the kinase family, specifically involved in mitochondrial regulation. The ADCK1 protein plays a critical role in maintaining mitochondrial structure and function, which is essential for cellular energy metabolism and homeostasis. It interacts with various mitochondrial proteins, such as YME1-like 1 ATPase (YME1L1) and optic atrophy 1 (OPA1), to regulate mitochondrial dynamics, including fusion and fission processes. These interactions are crucial for ATP production, reactive oxygen species (ROS) management, and apoptosis regulation. ADCK1's involvement in these processes suggests its significant role in cellular health and disease, including its implications in cancer progression and potential therapeutic targeting (Ji2021ADCK1; Yoon2019Drosophila).

## Function
ADCK1 (aarF domain containing kinase 1) is involved in maintaining mitochondrial structures and functions, crucial for cellular energy metabolism. It interacts with proteins such as YME1-like 1 ATPase (YME1L1) and optic atrophy 1 (OPA1) to regulate mitochondrial dynamics and cristae structure, which are essential for ATP production and reactive oxygen species (ROS) management (Yoon2019Drosophila). ADCK1's role in mitochondrial fusion and fission processes is mediated through its interaction with OPA1, affecting mitochondrial morphology and function (Yoon2019Drosophila). 

In healthy cells, ADCK1 is suggested to be part of a signaling pathway that includes YME1L1, IMMT, and OPA1, which collectively control mitochondrial fusion/fission, cristae remodeling, ATP and ROS production, and apoptosis (Yoon2019Drosophila). This regulation is vital for maintaining mitochondrial integrity and cellular health, impacting muscle function and development (Yoon2019Drosophila). 

While the specific functions of ADCK1 in healthy human cells are not fully detailed, its involvement in mitochondrial maintenance suggests a role in cellular energy metabolism and homeostasis, potentially influencing processes like cell proliferation and differentiation (Ji2021ADCK1).

## Clinical Significance
ADCK1 (aarF domain containing kinase 1) has been implicated in several diseases due to its altered expression and interactions. In osteosarcoma, a type of bone cancer, ADCK1 is significantly upregulated, promoting cell proliferation, migration, and resistance to apoptosis. Its overexpression is associated with increased tumor growth, while silencing or knockout of ADCK1 leads to reduced tumor growth and enhanced sensitivity to chemotherapy drugs like doxorubicin (Zhuo2022ADCK1). The mTOR signaling pathway is crucial for ADCK1 expression in osteosarcoma, and mTOR inhibitors can reduce ADCK1 levels, suggesting potential therapeutic strategies (Zhuo2022ADCK1).

In colon cancer, ADCK1 is also upregulated and activates the β-catenin/TCF signaling pathway, which is critical for cancer progression. This activation promotes tumor formation, metastasis, and poor patient survival. Targeting ADCK1 could serve as a therapeutic strategy, as its knockdown inhibits tumorigenesis and reduces cancer cell invasion (Ji2021ADCK1).

ADCK1 is involved in maintaining mitochondrial structures and functions. In Drosophila, ADCK1 deficiency leads to mitochondrial dysfunction, increased oxidative stress, and muscle abnormalities, suggesting its potential role in mitochondria-related muscular diseases (Yoon2019Drosophila).

## Interactions
ADCK1, also known as AarF domain-containing kinase 1, is involved in several protein-protein interactions that play a crucial role in cellular signaling pathways. In the context of colon cancer, ADCK1 interacts with the transcription factor TCF4, a key component of the Wnt/β-catenin signaling pathway. This interaction facilitates the formation of a complex with β-catenin, promoting the activation of downstream genes involved in cancer progression (Ji2021ADCK1). 

In Drosophila, ADCK1 is critical for maintaining mitochondrial structures and functions. It interacts with proteins such as YME1-like 1 ATPase (YME1L1), optic atrophy 1 (OPA1), and inner membrane mitochondrial protein (IMMT) to regulate mitochondrial dynamics, including fusion and fission processes (Yoon2019Drosophila). The interaction with YME1L1 is particularly significant, as it mediates the processing of OPA1, influencing mitochondrial morphology and function (Yoon2019Drosophila). 

In osteosarcoma, ADCK1 is associated with mitochondrial dysfunction when silenced, although specific protein interactions in this context are not detailed (Zhuo2022ADCK1). These interactions highlight ADCK1's role in both cancer progression and mitochondrial regulation.


## References


[1. (Ji2021ADCK1) Yong Ji, Yiqian Liu, Changchun Sun, Lijiang Yu, Zhao Wang, Xu Du, Wu Yang, Chenggong Zhang, Chunmu Tao, Jianjiang Wang, Xi Yang, Sun Di, and Yufeng Huang. Adck1 activates the β-catenin/tcf signaling pathway to promote the growth and migration of colon cancer cells. Cell Death &amp; Disease, April 2021. URL: http://dx.doi.org/10.1038/s41419-021-03624-9, doi:10.1038/s41419-021-03624-9. This article has 2 citations.](https://doi.org/10.1038/s41419-021-03624-9)

[2. (Zhuo2022ADCK1) Bao-biao Zhuo, Lun-qing Zhu, Chen Yao, Xi-hua Wang, Shi-xian Li, Rong Wang, Yuan Li, and Zhuo-yan Ling. Adck1 is a potential therapeutic target of osteosarcoma. Cell Death &amp; Disease, November 2022. URL: http://dx.doi.org/10.1038/s41419-022-05401-8, doi:10.1038/s41419-022-05401-8. This article has 7 citations.](https://doi.org/10.1038/s41419-022-05401-8)

[3. (Yoon2019Drosophila) Woongchang Yoon, Sun-Hong Hwang, Sang-Hee Lee, and Jongkyeong Chung. Drosophila adck1 is critical for maintaining mitochondrial structures and functions in the muscle. PLOS Genetics, 15(5):e1008184, May 2019. URL: http://dx.doi.org/10.1371/journal.pgen.1008184, doi:10.1371/journal.pgen.1008184. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1008184)